EMA
approval
· 2022-07-22
New medicine for multiple myeloma patients with limited treatment options
Summary
EMA announces a new medicine for multiple myeloma patients with limited treatment options, indicating a potential new treatment option in this niche patient pop…
Upgrade for the full analysis, importance score, and drug timeline.